Cinedigm forecast

 Cinedigm 

Do Wall Street analysts recommend investors buy shares of Cinedigm?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cinedigm in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." 

Corp., together with its subsidiaries, operates as distributor and aggregator of independent movie, television, and other short form content in the United States, Canada, and New Zealand. The company operates through two segments, Cinema Equipment Business and Content and Entertainment Business. It manages a library of distribution rights to various titles and episodes released across digital, physical, and home and mobile entertainment platforms, as well as services digital cinema assets on approximately 12,000 domestic and foreign movie screens. The company distributes its products for various brands, such as Hallmark, Televisa, ITV, Nelvana, ZDF, Shout! Factory, NFL, NHL and Scholastic, as well as international and domestic content creators, movie producers, television producers, and other short form digital content producers. It also collaborates with producers, various brands, and other content owners to market, source, curate, and distribute content to targeted audiences through existing and emerging digital home entertainment platforms, including Apple, Amazon Prime, Netflix, Hulu, Xbox, PlayStation, Sony, and cable/satellite video-on-demand; and distributes DVD and Blu-ray discs to wholesalers and retailers with sales coverage to approximately 60,000 brick and mortar storefronts, including Walmart, Target, Best Buy, and Amazon. In addition, the company operates various branded and curated over-the-top (OTT) entertainment channels, including Docurama, CONtv, and Dove Channel; and Matchpoint, a software-as-a-service platform to automate the distribution of streaming content and OTT channels. Cinedigm Corp. has a strategic alliance with Starrise Media Holdings Limited to release films in China theatrically and to digital platforms. The company was formerly known as Cinedigm Digital Cinema Corp. and changed its name to Cinedigm Corp. in September 2013. Cinedigm Corp. was founded in 2000 and is headquartered in New York, New York.Corp., together with its subsidiaries, operates as distributor and aggregator of independent movie, television, and other short form content in the United States, Canada, and New Zealand.

 The company operates through two segments, Cinema Equipment Business and Content and Entertainment Business. 

It manages a library of distribution rights to various titles and 

episodes released across digital,

 physical, and

 home and mobile entertainment platforms, 

as well as services digital cinema assets on approximately 12,000 domestic and foreign movie screens.

 The company distributes its products for various brands, such as Hallmark, Televisa, ITV, Nelvana, ZDF, Shout! Factory, NFL, NHL and Scholastic, as well as international and domestic content creators, movie producers, television producers, and other short form digital content producers. 

It also collaborates with producers, various brands, and other content owners to market, source, curate, and distribute content to targeted audiences through existing and emerging digital home entertainment platforms, including Apple, Amazon Prime, Netflix, Hulu, Xbox, PlayStation, Sony, and cable/satellite video-on-demand; and distributes DVD and Blu-ray discs to wholesalers and retailers with sales coverage to approximately 60,000 brick and mortar storefronts, including Walmart, Target, Best Buy, and Amazon. In addition, the company operates various branded and curated over-the-top (OTT) entertainment channels, including Docurama, CONtv, and Dove Channel; and Matchpoint, a software-as-a-service platform to automate the distribution of streaming content and OTT channels. Cinedigm Corp. has a strategic alliance with Starrise Media Holdings Limited to release films in China theatrically and to digital platforms. The company was formerly known as Cinedigm Digital Cinema Corp. and changed its name to Cinedigm Corp. in September 2013. Cinedigm Corp. was founded in 2000 and is headquartered in New York, New York.

Cinedigm -CIDM

Cinedigm Corp. (NASDAQ: CIDM) has always been considered a speculative stock among the movies, content and video segment.

https://wallmine.com/nasdaq/cidm

 Despite some major ongoing woes in the movie theater business and in the media business as a whole around the COVID-19 pandemic and around the recession that came from it, Cinedigm may have just given the company and its shareholders a new life in a deal that includes Amazon.com Inc. (NASDAQ: AMZN) via IMDb TV.

 The company may have also just created some serious bad blood for investors with a capital raise.

As with all small-cap and micro-cap companies making major media announcements, the question of how it will see revenues rise is likely to come into play. 

Some investors and speculators may question how much of a boost Cinedigm can expect to its revenues, and a strategy of a capital raise may bring additional questions on top of a history of declining revenues. 

Other investors and speculators may believe that any platform expansion may be the best thing that could ever happen.

IMDb TV is still a free streaming video service. Cinedigm indicated that it has thousands of premium movies and TV shows and is available as an app on Fire TV and as a free channel within the Prime Video and IMDb apps across hundreds of devices.

Cinedigm shares rose exponentially on the news, but the company also took the massive rise as an opportunity to raise capital to the tune of $8 million. The company is selling 10,666,666 shares of its own common shares at $0.75 per share. The sale is via a registered direct offering priced at-the-market under Nasdaq rules, and the sale is expected to close on May 22.

This company has also seen a less than impressive pattern of revenues from operations in recent years, and it has nothing to do with the recession. 

In Fiscal Year 2019 (ending in March), its revenues were only $53.53 million. That was down from $67.68 million in 2018 and down from $90.39 million in 2017.

Cinedigm was once given massive analyst upside in a research call from Macquarie in recent years, but the stock has remained in the realm of micro-caps.

Cinedigm shares had risen more than 300% to as high as $2.63 on Wednesday, but the news of the offering and the steep discount based on the highs had taken the stock all the way back down to $2.09 late in the day and then down to $1.27 as of the closing bell.

24/7 Wall St.
5 Dividend Aristocrat Stocks to Buy That Could Weather Another Brutal Sell-Off

Cinedigm’s stock faced multiple trading halts based on the share price gains on Wednesday, and it had traded nearly 81 million shares even before the market’s close. This stock was just at $0.62 as of Tuesday’s previous close, and its 52-week trading range had been $0.25 to $2.03 ahead of this news.

For further history, Cinedigm had been more than $8 in its stock price about 5 years ago and its shares were exponentially higher back before the Great Recession more than a decade ago.

 

Pump-and Dump Protection:

  Ruettiger’s scam feeds into this third one: 

unscrupulous investors who try to inflate a microcap’s price so they can dump shares at the top and make a fortune — right before the price crashes again.

 This is most easily achieved in microcaps with thin volume, because it’s easy to move the market with a low-priced stock that trades only a few thousand shares a day

. It’s an increasingly popular tactic — a Trustwave report recently showed that penny stock-touting messages accounted for “16% of unwanted email in 2013, up from less than 1% the year before,” according to MarketWatch.

 You can protect yourself by looking for more liquid stocks that trade on higher volume, and even then, it’s a good idea to use a limit order to prevent buying shares at a higher price than you expected.

un·scru·pu·lous

/ˌənˈskro͞opyələs/

Learn to pronounce

adjective

1. having or showing no moral principles; not honest or fair.

 

Penny Stocks – How to Profit Without Getting Scammed

There's nothing illegal about penny stocks as a whole, but they're a popular stomping ground for scam artists

By Jeff Reeves May 31, 2014, 5:00 am EST

Penny stocks are a popular way for many folks to invest.

But that’s a problem, because penny stocks also are a highly volatile and risky asset class that have left many investors in tears over the years.

The risks of penny stock investing are so acute, in fact, that the U.S. Securities and Exchange Commission has a host of resources and publications to ensure investors know what they are getting into. One such SEC webpage on penny stock rules warns the following (emphasis theirs, not mine):

“Penny stocks may trade infrequently, which means that it may be difficult to sell penny stock shares once you own them. Moreover, because it may be difficult to find quotations for certain penny stocks, they may be difficult, or even impossible, to accurately price. For these, and other reasons, penny stocks are generally considered speculative investments. Consequently, investors in penny stocks should be prepared for the possibility that they may lose their whole investment (or an amount in excess of their investment if they purchased penny stocks on margin).”

This is only the beginning of your risk if you invest in penny stocks, however.

From Suspect Investment to Outright Scam

Even worse than buying shares of a legitimate company that goes bankrupt is the idea of plowing your hard-earned cash into a penny stock scam, where no real business actually exists.

That’s what happened to investors last year who bought into a sophisticated penny stock scam ring, and were fleeced out of $140 million because they believed in a “revolutionary” fertilizer company called Resource Group International.

Think the 2000 movie Boiler Room. Well, that kind of stuff isn’t fiction.

I personally don’t ever invest in penny stocks because of the volatility and risk. Nor do I recommend any other investors do so because there are plenty of alternatives out there with better liquidity and transparency than microcaps trading on the pink sheets.

But hey, I also don’t smoke cigarettes or race motorcycles. What you choose to do with your money, on your time, is your own business … and if you’re comfortable with the risks, then it’s not my place to judge.

If you are investing in penny stocks, though, here are a few tips I think you should review to ensure your investments stay out of the hands of fraudsters:

Beware False Products, Not Just False Promises: Fluffy marketing about your product is one thing, but faking contracts or referring to a big deal that never happened are other matters — and against the law. Many companies claim to have products that will “revolutionize” an industry, and false promises are sadly just a way of the advertising world. But research what you can, where you can to ensure that the products themselves are real and that revenue actually exists somewhere.

Shun Celebrity Investment Tips: Penny stocks aren’t above paying someone to tout their company. Daniel “Rudy” Ruettiger of Notre Dame walk-on fame paid $382,866 (though did not have to admit guilt) in a settlement for his antics in a tiny sports drink company called, obviously, Rudy. Rapper 50 Cent was paid to talk up a penny stock on Twitter. Again, marketing is one thing … but there’s a big difference between William Shatner telling you to book a flight on Priceline.com (PCLN) and William Shatner taking to the airwaves to tell you explicitly to invest in PCLN stock.

15 TECH STOCKS SET TO CASH IN ON THE 5G REVOLUTION

Want to Protect Yourself? Try Reading.

Again, penny stocks are a highly risky asset class where even reasonably legitimate companies can go bankrupt. It is on every investor to do his or her own research and look seriously at microcap stocks before simply buying in based on a narrative of once-in-a-lifetime opportunities.

And remember this above all: Over-the-counter and pink-sheet stocks are still subject to SEC oversight, and by law have to file certain documentation. That is your best hope of getting the real story.

Take the hilariously named Great Idea Corp, a penny stock incorporated in 2011 that has one of the most absurd prospectuses I have ever read.

Here’s an excerpt:

“The Company was formed by Nishon Petrossian, the initial director, for the purpose of creating a corporation which could be used to consummate a merger or acquisition. Mr. Petrossian serves as President, Secretary, Treasurer and Director. Mr. Petrossian determined next to proceed with filing a Form S-1. Mr. Petrossian has no specific experience, qualification, attributes or skills to perform as a director of a blank check company nor in the acquisition of acquisition candidates.”

Got that? A guy with zero experience or skill wants to raise money to acquire another company … nice dream!

It gets even better, with clauses that allowed Petrossian sole discretion over executive compensation (just his, of course, since he serves in all four senior roles), and furthermore that “The Offering Price of the Shares bears no relation to book value, assets, earnings, or any other objective criteria of value. They have been arbitrarily determined by the Company.”

What could go wrong?

Thankfully, Great Idea Corp is no longer out there — because, as should be evident, it was a penny stock doomed to go to zero.

But it is highly instructive that a company like filed with the SEC at all.

Bottom Line

The best way to protect against penny stock losses — either through fraud or just bonehead ideas — is to actually know where the money is going. If you don’t take the time to read through documents or at least poke around the Internet, expect to get burned or ripped off.

Read More From ‘Cheated’

• 10 Internet Scams to Watch Out For
• 10 of the World’s Craziest Ponzi Schemes
• When Fraud Bites Business: Lost Fortunes, Reputations and Lives
• 3 Big Ways That Medicare Fraudsters Rip You Off

Jeff Reeves is the editor of InvestorPlace.com and the author of The Frugal Investor’s Guide to Finding Great Stocks. As of this writing, he did not hold a position in any of the aforementioned securities. Write him at editor@investorplace.com or follow him on Twitter via @JeffReevesIP. 

---

Man Who Recommended Apple at $1.49 Reveals #1 5G Play

CIDM forecast

 The 2 analysts offering 12-month price forecasts for Cinedigm Corp have a median target of 2.75, with a high estimate of 3.50 and a low estimate of 2.00.

 The median estimate represents a +428.85% increase from the last price of 0.52.

The 2 analysts offering 12-month price forecasts for Cinedigm Corp have a median target of 2.75, with a high estimate of 3.50 and a low estimate of 2.00. The median estimate represents a +298.49% increase from the last price of 0.69. CNN Business 

Cinedigm's stock was trading at $0.3848 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CIDM stock has increased by 81.5% and is now trading at $0.6985.(as of 12/05/2020 December)  rising from 0.52 on 12/03/2020 after streaming.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cinedigm in the last year.

 There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."

Wall Street analysts have given Cinedigm a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. 

MarketBeat just released five new trading ideas, but Cinedigm wasn't one of them.

MarketBeat thinks these five stocks may be even better buys.

Cinedigm Corp - Class A stock forecast, CIDM price prediction: Buy or sell Cinedigm Corp. shares?

by Gov Capital

CIDM Price is 0.700 USD today.

1 year Cinedigm Corp - Class A Forecast: 1.156288 *

5 year Cinedigm Corp - Class A Forecast: 1.174 *

Cinedigm News: Why CIDM Stock Is Soaring Today

CIDM stock is cruising higher because of this major company move

By Nick Clarkson, Web Editor Dec 4, 2020, 11:24 am EST

Shares of Cinedigm (NASDAQ:CIDM) stock are quickly rising on Friday morning after an important company announcement on Thursday.

Source: Pavel Kapysh / Shutterstock.com

The firm released a statement that its linear streaming channels are now available on Rad, a livestreaming platform with a diverse lineup of content for its users. It is quickly growing, and the company said that Rad reaches 110 million Sony (NYSE:SNE) PlayStation consoles. Additionally, it reaches “hundreds of millions” of other mobile streaming devices.

Additionally, the Los Angeles-based company boasts that it is the “leading independent entertainment studio in North America….” and focuses on a number of different areas. This includes digital cinema and streaming channels, as well as content and marketing distribution. Also, Rad works with some of the biggest names in entertainment like Discovery (NASDAQ:DISCA), ViacomCBS (NASDAQ:VIAC) and Showtime.

Overall, this is major news for this firm — and CIDM stock is getting a boost because of it.

15 TECH STOCKS SET TO CASH IN ON THE 5G REVOLUTION

Moreover, Erick Opeka — president of Cinedigm Networks — had this to say about the CIDM stock news:

“Rad exemplifies exactly what we look for in a platform distribution partner. Between their unique reach on 110 million gaming consoles, extensive premium content, and an innovative discovery and viewing experience, they are the perfect home for our growing stable of enthusiast networks.”

CIDM stock was up nearly 25% as of Friday morning.

On the date of publication, Nick Clarkson did not have (either directly or indirectly) any positions in the securities mentioned in this article. 

Nick is a web editor at InvestorPlace.

On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. 

That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators.

If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.

Read More: Penny Stocks — How to Profit Without Getting Scammed

52 Stocks Moving In Friday's Mid-Day Session

 

52 Stocks Moving In Friday's Mid-Day Session

12/4/20 12:00 PM ET (Benzinga)Print

Gainers

• China HGS Real Estate Inc. (NASDAQ: HGSH) climbed 179% to $4.9150 after climbing over 21% on Thursday.
• 
  
• Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares climbed 50% to $5.33 after the company announced a conclusive settlement with Myers Power Products.
• Fangdd Network Group Ltd. (NASDAQ: DUO) shares surged 48.7% to $10.20.
• 
  
• Star Peak Energy Transition Corp. (NYSE: STPK) gained 35.7% to $13.65. Stem reported a deal with Star Peak Energy Transition for a business combo.
• CIIG Merger Corp. (NASDAQ: CIIC) climbed 33.5% to $28.77 following a positive mention of the stock by Jim Cramer on CNBC's 'Mad Money' show. The company’s stock surged around 10% on Thursday.
• Sutro Biopharma, Inc. (NASDAQ: STRO) surged 33% to $22.60 after the company reported interim data on STRO-002 Phase 1 dose-escalation study for patients with ovarian cancer.
• Luminar Technologies (NASDAQ: LAZR) climbed 31.4% to $30.20 after climbing around 28% on Thursday.
• 
  
• MDJM Ltd. (NASDAQ: MDJH) gained 25.8% to $4.48.
• AquaBounty Technologies, Inc. (NASDAQ: AQB) shares rose 26.2% to $7.95.
• Cinedigm Corp. (NASDAQ: CIDM) surged 25.7% to $0.7037. 
• Cinedigm recently announced eight of its linear streaming channels have launched on Rad streaming service.
• Callon Petroleum Company (NYSE: CPE) gained 22.8% to $13.28.
• PagerDuty, Inc. (NYSE: PD) rose 21.7% to $39.40 after the company reported better-than-expected Q3 results. The company also issued strong Q4 and FY21 sales guidance .
• Impac Mortgage Holdings, Inc. (NYSE: IMH) surged 21% to $2.8964.
• Collective Growth Corporation (NASDAQ: CGRO) climbed 20.9% to $11.95. Innoviz Technologies Ltd is reportedly deliberating a public listing in the U.S. through a merger with a special purpose acquisition company. Bloomberg reported that blank check company Collective Growth is seeking to raise between $100 million to $350 million in funding for the acquisition.
• Hexindai Inc. (NASDAQ: HX) gained 19% to $2.88.
• Medalist Diversified REIT, Inc. (NASDAQ: MDRR) surged 18.4% to $2.70.
• Alaska Communications Systems Group, Inc. (NASDAQ: ALSK) gained 18% to $3.60 after the company reported expiration of go-shop period. The company received 2 acquisition proposals and determined the superior offer at $3.15 per share.
• Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) climbed 17.9% to $7.20. Merrimack Pharmaceuticals shares jumped 59% on Wednesday following a timeline announcement for a potential Onivyde milestone payment which was announced at a corporate presentation by Ipsen S.A.
• Evogene Ltd. (NASDAQ: EVGN) gained 17% to $4.35. Evogene reported Q3 results last month.
• BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 16.8% to $6.00 after the company reported the FDA approval of ORLADEYO to prevent attacks in hereditary angioedema patients.
• Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) rose 16.7% to $1.5855 after surging 16% on Thursday. Foresight will showcase its mass screening COVID-19 symptom detection solution in the United Arab Emirates at GITEX Future Stars 2020 Dec. 7-9.
• Kubient, Inc. (NASDAQ: KBNT) shares climbed 16.4% to $5.68 after climbing around 23% on Thursday.
• Funko, Inc. (NASDAQ: FNKO) gained 16.3% to $9.84.
• Sigma Labs, Inc. (NASDAQ: SGLB) rose 16.2% to $3.3001 after gaining over 4% on Thursday.
• Domo, Inc. (NASDAQ: DOMO) gained 15.5% to $44.20 after the company reported better-than-expected Q3 results. Needham and Credit Suisse raised their price targets on the stock.
• United Microelectronics Corporation (NYSE: UMC) rose 14.5% to $8.88 after climbing over 6% on Thursday.
• Novan, Inc. (NASDAQ: NOVN) climbed 13.3% to $0.6331 after climbing over 8% on Thursday. Novan was recently granted U.S. patent titled 'Combinations and methods for the treatment and/or prevention of fungal infections.'
• NCR Corporation (NYSE: NCR) surged 12.9% to $35.36. Stephens & Co. and Morgan Stanley raised their price targets on the stock.
• Atlas Technical Consultants, Inc. (NASDAQ: ATCX) gained 12.6% to $7.08.
• Continental Resources, Inc. (NYSE: CLR) gained 12.4% to $18.04. Continental Resources reported a partial redemption of 5% senior notes due 2022. Truist Securities upgraded Continental Resources from Hold to Buy and announced a $22 price target.
• U.S. Silica Holdings, Inc. (NYSE: SLCA) surged 11.5% to $5.82. U.S. Silica recently announced up to 15% price increases on industrial and specialty products.
• Cloudera, Inc. (NYSE: CLDR) rose 9.8% to $12.71 after the company reported better-than-expected Q3 results and issued upbeat FY21 guidance.
• ReTo Eco-Solutions, Inc. (NASDAQ: RETO) shares rose 7.2% to $0.7450 after gaining over 3% on Thursday.
• DocuSign, Inc. (NASDAQ: DOCU) rose 7% to $247.12 after the company reported better-than-expected Q3 results and issued strong sales guidance.
• MIND Technology, Inc. (NASDAQ: MIND) rose 6.5% to $2.61 after the company reported Q3 results.

Check out these big penny stock gainers and losers

Losers

• Precision BioSciences, Inc. (NASDAQ: DTIL) shares tumbled 21.4% to $8.04 after reporting interim clinical results from its Phase 1/2a study of PBCAR0191.
• Ever-Glory International Group, Inc. (NYSE: EVK) shares dipped 19.8% to $4.2115 after jumping 150% on Thursday. The company released quarterly results last month.
• Cortexyme, Inc. (NASDAQ: CRTX) shares declined 18% to $39.30 as the company announced that the independent Data Monitoring Committee conducted a pre-planned interim analysis and recommended Cortexyme continue the Phase 2/3 GAIN trial of its Alzheimer's candidate atuzaginstat as planned to the 1-year endpoint. Top-line results are expected as planned in December 2021.
• Kaixin Auto Holdings (NASDAQ: KXIN) shares fell 17.7% to $5.40.
• Lizhi Inc. (NASDAQ: LIZI) dropped 17.4% to $3.9550. Lizhi shares jumped over 100% on Thursday after the company entered into in-car audio collaboration with Xpeng Motors.
• Yext Inc (NYSE: YEXT) fell 16.9% to $16.06 after the company issued weak Q4 sales guidance.
• Cambium Networks Corporation (NASDAQ: CMBM) dipped 14.3% to $25.83 after the company reported pricing of secondary offering.
• Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares fell 13.7% to $6.48 after the company announced the FDA rejected its EUA application for rapid antibody test panel, stating the EUA is not a priority.
• Tilly's, Inc. (NYSE: TLYS) dropped 12.8% to $8.20 after the company reported a drop in quarterly earnings.
• Medallia, Inc. (NASDAQ: MDLA) fell 11.8% to $30.99 after the company reported Q3 earnings results.
• Meten EdtechX Education Group Ltd. (NASDAQ: METX) declined 11.6% to $2.96 following Q3 results.
• Cellectar Biosciences, Inc. (NASDAQ: CLRB) fell 11.2% to $2.0692 after surging over 19% on Thursday.
• Ollie's Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) shares dropped 11% to $79.73 despite reporting better-than-projected quarterly results.
• China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares fell 9.9% to $0.3420. China SXT Pharmaceuticals shares jumped around 24% on Thursday after the company entered a 12 million share securities purchase agreement with an investor.
• Big Lots, Inc. (NYSE: BIG) fell 8.4% to $48.41 despite reporting upbeat quarterly earnings.
• Marvell Technology Group Ltd. (NASDAQ: MRVL) fell 5.6% to $42.99. Marvell Technology reported in-line earnings for its third quarter, while sales missed estimates. The
• NanoVibronix, Inc. (NASDAQ: NAOV) fell 4.4% to $1.08. NanoVibronix recently priced its 8.57 million share offering at $0.70at share.

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Back to News Overview